文献速递淋巴瘤

特定非霍奇金淋巴瘤亚型成年幸存者中感染性病因相关恶性肿瘤风险

Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
PubMed 文献 · Blood Adv · 2019-01-01

基于美国人群癌症登记数据,分析127 044例四种常见非霍奇金淋巴瘤(NHL)成年1年幸存者2000-2014年诊断后随访(平均4.5-5.2年),量化感染性病因相关实体恶性肿瘤风险。弥漫大B细胞淋巴瘤(DLBCL)和边缘区淋巴瘤(MZL)幸存者肝癌、胃癌、肛门癌风险升高,而滤泡性淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤未见升高。DLBCL幸存者中HIV感染者肛门癌风险尤为升高。

要点

  • DLBCL幸存者肝癌SIR 1.85、胃癌SIR 1.51、肛门癌SIR 3.71,均高于一般人群。
  • MZL幸存者肝癌SIR 1.98、胃癌SIR 2.78、肛门癌SIR 2.36,均高于一般人群。
  • DLBCL幸存者中HIV感染者肛门癌SIR 68.34,无HIV感染者SIR 2.09。

核心结论

  • DLBCL和MZL幸存者中感染性病因相关实体癌风险升高,且模式因NHL亚型而异。

研究设计与样本

  • 基于美国人群癌症登记数据,纳入127 044例2000-2014年诊断的四种常见NHL成年1年幸存者,平均随访4.5-5.2年。

主要发现

  • DLBCL幸存者肝癌SIR 1.85(95%CI 1.46-2.31)、胃癌SIR 1.51(95%CI 1.16-1.94)、肛门癌SIR 3.71(95%CI 2.52-5.27),均高于一般人群。
  • MZL幸存者肝癌SIR 1.98(95%CI 1.34-2.83)、胃癌SIR 2.78(95%CI 2.02-3.74)、肛门癌SIR 2.36(95%CI 1.02-4.64),均高于一般人群。
  • 滤泡性淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤幸存者肝癌、胃癌、肛门癌风险未见升高。
  • DLBCL幸存者中HIV感染者肛门癌SIR 68.34(95%CI 37.36-114.66),无HIV感染者SIR 2.09(95%CI 1.22-3.34)。
  • 任何NHL亚型幸存者宫颈癌和口咽/扁桃体癌风险均未升高。

临床怎么用

  • DLBCL和MZL幸存者后续肝癌、胃癌、肛门癌风险升高,可能有助于指导这些幸存者的监测。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infectious agents have been identified in the etiology of certain non-Hodgkin lymphoma (NHL) subtypes and solid tumors. The impact of this shared etiology on risk for second cancers in NHL survivors has not been comprehensively studied. We used US population-based cancer registry data to quantify risk of solid malignancies associated with infectious etiology among 127 044 adult 1-year survivors of the 4 most common NHL subtypes diagnosed during 2000 to 2014 (mean follow-up, 4.5-5.2 years). Compared with the general population, elevated risks for liver, stomach, and anal cancers were observed among diffuse large B-cell lymphoma (DLBCL) survivors (standardized incidence ratio [SIR], 1.85; 95% confidence interval [CI], 1.46-2.31; SIR, 1.51; 95% CI, 1.16-1.94; SIR, 3.71; 95% CI, 2.52-5.27, respectively) and marginal zone lymphoma (MZL; SIR, 1.98; 95% CI, 1.34-2.83; SIR, 2.78; 95% CI, 2.02-3.74; SIR, 2.36; 95% CI, 1.02-4.64, respectively) but not follicular lymphoma or chronic lymphocytic leukemia/small lymphocytic lymphoma. Anal cancer risk was particularly elevated among DLBCL survivors with HIV (SIR, 68.34; 95% CI, 37.36-114.66) vs those without (SIR, 2.09; 95% CI, 1.22-3.34). The observed patterns are consistent with shared associations between these cancers and hepatitis C virus, Helicobacter pylori, and HIV, respectively. In contrast, risks for cervical and oropharyngeal/tonsil cancers were not elevated among survivors of any NHL subtype, possibly because of the lack of NHL association with human papillomavirus or population-wide screening practices (for cervical cancer). In summary, patterns of elevated second cancer risk differed by NHL subtype. Our results suggest shared infectious etiology has implications for subsequent cancer risks among DLBCL and MZL survivors, which may help inform surveillance for these survivors.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Herr MM, Schonfeld SJ, Dores GM, et al. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Blood Adv. 2019. PMID: 31262739. doi:10.1182/bloodadvances.2019030924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。